This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Dec 15;370(9604):2000; author reply 2000-1.

doi: 10.1016/S0140-6736(07)61854-6.

Treating clinically isolated syndromes suggestive of MS

Charles M Poser

PMID: 18083395
DOI: 10.1016/S0140-6736(07)61854-6

Comment

Treating clinically isolated syndromes suggestive of MS

Charles M Poser. Lancet. 2007.

. 2007 Dec 15;370(9604):2000; author reply 2000-1.

doi: 10.1016/S0140-6736(07)61854-6.

Author

Charles M Poser

PMID: 18083395
DOI: 10.1016/S0140-6736(07)61854-6

No abstract available

PubMed Disclaimer

Comment on

Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study.
Kappos L, Freedman MS, Polman CH, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Radü EW, Bauer L, Dahms S, Lanius V, Pohl C, Sandbrink R; BENEFIT Study Group. Kappos L, et al. Lancet. 2007 Aug 4;370(9585):389-97. doi: 10.1016/S0140-6736(07)61194-5. Lancet. 2007. PMID: 17679016 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information